5-HT/CGRP pathway and Sumatriptan role in Covid-19

Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Nobendu Mukerjee, Sadiq Mohammed J. Al-Hamash, Thabat J. Al-Maiahy, Gaber El-Saber Batiha

DOI: 10.1080/02648725.2022.2108996

Journal: Biotechnology and Genetic Engineering Reviews

Sumatriptan might be a novel potential therapeutic strategy in managing Covid-19 through modulation of 5-HT neurotransmitters and inhibiting CGRP because of its anti-inflammatory and antioxidant properties.

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Download ivySCI

Journal Info

Journals:

ISSN 0264-8725

Quartile

CategoryQuartile
GENETICS & HEREDITY1

Quartile(CN)

CategoryQuartile
工程技术3
工程技术, 生物工程与应用微生物4
工程技术, 遗传学4
Built withby Ivy Science